Catalyst Pharmaceuticals(US:CPRX) Globenewswire·2026-02-11 13:03Core Viewpoint - Catalyst Pharmaceuticals, Inc. will release its fourth quarter and full-year 2025 financial results on February 25, 2026, followed by a conference call and webcast on February 26, 2026, at 8:30 AM ET to discuss these results and provide a business update [1][2]. Group 1: Financial Results Announcement - The company will announce its financial results after the market close on February 25, 2026 [1]. - A conference call and webcast will be held on February 26, 2026, at 8:30 AM ET to discuss the financial results [2]. Group 2: Conference Call & Webcast Details - The US/Canada dial-in number for the conference call is (800) 715-9871, and the international dial-in number is (646) 307-1963 [3]. - The webcast will be accessible on the company's website, with a replay available for at least 30 days following the event [3]. Group 3: Company Overview - Catalyst Pharmaceuticals is focused on developing and commercializing novel medicines for patients with rare diseases [4]. - The company has been recognized by Forbes as one of America's Most Successful Companies in 2023, 2024, and 2025, and listed on the 2025 Deloitte Technology Fast 500™ as one of North America's Fastest-Growing Companies [4].